Spravato Treatment in Arlington
Living with depression that resists multiple medications can feel like walking uphill with no summit in sight. Our Arlington office provides Spravato Treatment and offers a fresh route forward by delivering esketamine, an FDA-approved nasal spray, under strict medical supervision for adults whose major depressive disorder (MDD) has not improved after two or more adequate antidepressant trials.
At Bloom Health Centers, neighborhood accessibility meets rigorous safety standards. You work with clinicians experienced in treatment-resistant depression who explain every step, track your vital signs in real time, and follow up between visits so progress feels concrete, not theoretical.
Who Is Considered for Spravato Therapy?
Spravato is indicated for adults in Arlington with treatment-resistant MDD and, under specific criteria, for adults experiencing depressive symptoms with acute suicidal ideation or behavior. Eligibility is confirmed through a detailed evaluation that:
- Reviews your complete medication history and prior dosages
- Screens for uncontrolled hypertension, cardiovascular disease, or a history of aneurysm
- Assesses substance-use history and your current medications to avoid harmful interactions
- Plans safe transportation, because REMS guidelines prohibit driving or operating heavy machinery until the day after treatment and after a restful night’s sleep
This careful vetting protects your safety and clarifies how Spravato will fit into your weekly routine.
Demystifying Coverage and Cost of Esketamine
Spravato is a specialty medication, so prior authorization is almost always required. Our based billing coordinators will gather your medication history, submit the paperwork, and respond promptly to insurer questions, reducing administrative delays. Many large commercial plans and some Medicaid programs cover esketamine for Arlington residents when criteria for treatment-resistant depression are met; however, co-pays can vary widely. We will give you a written cost estimate before your first dose, then revisit it whenever your insurer updates its policy.
What to Expect on Treatment Days
Each esketamine nasal-spray session in Arlington follows a predetermined protocol:
- Check-In (15 min): We measure your blood pressure, pulse, and oxygen saturation before your Spravato administration.
- Spravato Self-administration (10-15): You spray a pre-measured dose into each nostril under staff guidance.
- Observation (2 hr): Our trained clinicians monitor your vitals in a low-stimulus room; you may rest, listen to music, or practice breathing exercises if mild dissociation occurs.
- Discharge Review (10 min): We note any side effects you may experience. We also provide you with after-visit instructions and our staff confirms your pre-arranged ride home.
The initial phase involves two visits per week, for four weeks, followed by weekly visits for four weeks, then a maintenance phase of weekly to bi-weekly visits.
What the Evidence Says About Spravato Results
Clinical trials of esketamine therapy show promising, but not universal, relief. In a pooled analysis of pivotal studies, 45 – 55 percent of participants experienced a clinically meaningful symptom drop by week four, and 25 – 40 percent achieved remission by week eight (Daly et al., 2019; Popova et al., 2019). Maintenance research suggests that continuing doses every one to two weeks cuts relapse risk roughly in half compared with oral antidepressant therapy alone (Fedgchin et al., 2019). Real-world registries echo these numbers, noting faster improvement in energy and motivation than traditional medications typically deliver.
That said, responses vary: some people feel better after the first two sessions, while others need the full induction phase before momentum builds. Regular mood-rating scales and candid check-ins let us fine-tune your schedule – or pivot to additional supports – so progress remains measurable and meaningful.
Call Us to Discuss Spravato Therapy in Arlington Today
Advanced options feel less daunting with informed guidance. Contact Bloom Health Centers in Arlington to learn whether Spravato treatment aligns with your path toward relief. Our experienced team is ready to answer questions, verify your benefits, and schedule your evaluation – so you can step onto a clearer and evidence-guided path forward.
References
Daly EJ, Trivedi MH, Janik A, et al. (2019). Efficacy of intranasal esketamine plus oral antidepressant in treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry, 76(9), 893-903.
Popova V, Daly EJ, Trivedi M, et al. (2019). A flexible-dose study of esketamine nasal spray combined with a new oral antidepressant for treatment-resistant depression. American Journal of Psychiatry, 176(6), 428-438.
Fedgchin M, Trivedi M, Daly EJ, et al. (2019). Maintenance of response with fixed-dose esketamine nasal spray in adults with treatment-resistant depression: results of a randomized withdrawal study. International Journal of Neuropsychopharmacology, 22(10), 724-736.
Bloom Tips and Tools
Bloom Services:
Learn more about our comprehensive range of mental health services and schedule an appointment today!
Bloom Blog:
Helpful insights and information for your mental health journey.
Bloom In The News:
Press releases, announcements, and mentions in other media sources.
have questions?
We’re here to answer them. Request an appointment through our online form.